Compare EQH & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | SMTI |
|---|---|---|
| Founded | 1859 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 313.5M |
| IPO Year | 2017 | 2008 |
| Metric | EQH | SMTI |
|---|---|---|
| Price | $53.09 | $34.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $56.82 | $34.00 |
| AVG Volume (30 Days) | ★ 3.0M | 357.5K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.60% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $11,665,000,000.00 | $15,586,976.00 |
| Revenue This Year | $43.13 | $17.31 |
| Revenue Next Year | $7.45 | $12.48 |
| P/E Ratio | $105.60 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $35.20 | $16.05 |
| 52 Week High | $55.15 | $35.70 |
| Indicator | EQH | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 66.31 | 80.92 |
| Support Level | $47.10 | $20.47 |
| Resistance Level | N/A | $34.33 |
| Average True Range (ATR) | 1.58 | 0.67 |
| MACD | 0.21 | 0.03 |
| Stochastic Oscillator | 94.19 | 97.66 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.